Mortality among Children with Sickle Cell Disease Identified by Newborn Screening during 1990-1994 - California, Illinois, and New York

Morbidity and Mortality Weekly Report

Volumn 47, Issue 9, 1998, Pages 169-172

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; INFANT; MORTALITY; NEGRO; NEWBORN; NEWBORN SCREENING; PRESCHOOL CHILD; SICKLE CELL TRAIT; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; CALIFORNIA; CHILD, PRESCHOOL; HUMANS; ILLINOIS; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; NEW YORK; SICKLE CELL TRAIT;

EID: 0032512930     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Sickle Cell Disease Guideline Panel. Sickle cell disease: screening, diagnosis, management, and counseling in newborns and infants. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993. (Clinical practice guideline no. 6).
2. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med 1986;314:1593-9.
3. Anderson RN, Kochanek KD, Murphy SL. Report of final mortality statistics, 1995. Hyattsville, Maryland: US Department of Health and Human Services, CDC, National Center for Health Statistics, 1997. (Monthly vital statistics report; vol 45, no. 11, suppl 2).
4. Reid CD, Charache S, Lubin B, eds. Management and therapy of sickle cell disease. 3rd ed. Bethesda, Maryland: US Department of Health and Human Services, National Institutes of Health, 1995; publication no. 96-2117.
5. Davis H, Schoendorf KC, Gergen PJ, Moore RM Jr. National trends in the mortality of children with sickle cell disease, 1968 through 1992. Am J Public Health 1997;87:1317-22.
6. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatrics 1988;81:749-55.
7. Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Pediatrics 1989;84:500-8.
8. Panny S. The Maryland sickle cell disease program: evaluating program effectiveness. Presented at the 1997 National Sickle Cell Disease Conference, Washington, DC, September 1997.
9. Khoury MJ, Genetics Working Group. From genes to public health: the applications of genetic technology in disease prevention. Am J Public Health 1996;86:1717-22.